A new database will collect information from clinicians about COVID-19-related neurological symptoms, complications, and outcomes as well as the effects of COVID-19 on pre-existing neurological conditions.
The COVID-19 Neuro Databank / Biobank (NeuroCOVID), created and maintained by NYU Langone Health, New York City, will be a resource of clinical information as well as biospecimens from people of all ages who have experienced complications. connected brain. the SARS-CoV-2 disease. The database is supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NINDS).
We know that COVID-19 can disrupt many body systems but the effects of the virus and the body’s response to COVID-19 infection on the brain, spine, nerves and muscles can be particularly devastating, and increase disability survival even after the virus has cleared. There is an urgent need to understand brain problems associated with COVID-19, which do not routinely include headaches, fatigue, mental disorders, stroke, pain, and sleep disorders as well as some very rare complications of serious diseases. “
Barbara Karp, MD, Program Director, NINDS
Participating healthcare providers and clinical sites across the United States are invited to use the web-based data portal to submit anonymous information into the database, along with biospecimens relevant collected during research studies or from previous clinical and experimental methods.
Information collected in the database includes neurological symptoms, comorbidities, course of disease, complications, sequelae, and outcomes. A Global Identifier Identifier (GUID) is used to identify data and biospecimens from each individual without personally identifiable information collected or stored in the database.
Scientists can access NeuroCOVID for research studies on the prevention, management, and treatment of COVID-19-related brain disorders. The database may provide an insight into how COVID-19 affects the nervous system, and how common, or rare, these problems are.
The project is led by Andrea Troxel, Sc.D., professor of population health at NYU Grossman School of Medicine, and Eva Petkova, Ph.D., professor of population health and child and adolescent psychiatry at the School of Medicine NYU Grossman. Researchers and clinicians can request access to the database through the NeuroCOVID website.
Source:
NIH / National Institute of Neurological Disorders and Stroke